28 results
8-K
EX-99.1
COGT
Cogent Biosciences Inc
14 Jun 19
Unum Therapeutics Strengthens and Expands Leadership Team
12:00am
Exhibit 99.1
Unum Therapeutics Strengthens and Expands Leadership Team
– Matthew Osborne Appointed as Chief Financial Officer –
– Jessica Sachs … to treat cancer based on its novel T cell technology platforms, today announced new additions to its leadership team. Matthew Osborne will be joining
8-K
EX-99.1
COGT
Cogent Biosciences Inc
26 Oct 20
Cogent Biosciences Appoints
7:13am
into the future.”
Mr. Harwin continued, “We extend our deep appreciation and gratitude to Chuck for his excellent leadership over the years and commend his … , development, and strategic leadership experience during a 20-year career in the pharmaceutical industry, with a specific focus on oncology and hematology
8-K
EX-99.1
COGT
Cogent Biosciences Inc
15 Mar 22
Cogent Biosciences Provides Corporate Updates, Fourth Quarter
8:08am
to joining Cogent, she held several leadership roles with increasing responsibilities, most recently leading clinical stage programs at both Boston … . Sun joins with over 20 years of industry experience with demonstrated leadership in clinical pharmacology, translational medicine, and DMPK
8-K
COGT
Cogent Biosciences Inc
26 Oct 20
Cogent Biosciences Appoints
7:13am
is an accomplished executive with extensive commercial, development and strategic leadership experience during a 20-year career in the pharmaceutical … unit and Vice President of Corporate Development. Prior to Hospira, Mr. Robbins held commercial and leadership positions within Pfizer’s oncology unit
8-K
EX-99.1
91jsj 8xw
13 Jan 20
Regulation FD Disclosure
7:42am
8-K
EX-99.1
a9b0 10um
16 Mar 21
Cogent Biosciences Reports Fourth Quarter 2020
7:15am
8-K
EX-99.1
0xk 3jtu2
12 May 21
Cogent Biosciences Provides Corporate Updates and Reports First Quarter 2021 Financial Results
7:14am
8-K
EX-99.1
uhbjstqjhj5k1e5kn
30 Nov 20
Other Events
5:06pm
8-K
EX-99.1
1vks mnfpfe6rz9o
12 Aug 19
Unum Therapeutics Reports Second Quarter 2019 Financial Results
4:12pm
8-K
EX-99.1
45pm6wvxylwayg8
7 Mar 19
Regulation FD Disclosure
2:02pm
8-K
EX-99.1
zzj689ey9 7ktjxk3
29 Jul 19
Unum Therapeutics Announces New Appointments to its Board of Directors
7:24am
8-K
EX-99.1
1idz56d v0
7 Jan 19
Regulation FD Disclosure
8:02am
8-K
v1cd aubfomjyft7ujmo
14 Jun 19
Unum Therapeutics Strengthens and Expands Leadership Team
12:00am
8-K
EX-99.1
92ppv61vy
9 Aug 22
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2022 Financial Results
7:15am
DEF 14A
binrj 9ui
30 Apr 19
Definitive proxy
5:25pm